Tagged With multiple sclerosis

New research funded by the National Institutes of Health suggests an experimental drug can slow down the brain damage caused by a form of multiple sclerosis (MS), an incurable neurological disorder that eats away at the protective coating of our nervous system. But it's still unclear whether the drug can noticeably improve the crippling symptoms sufferers experience.

Canadian scientists have uncovered a single genetic mutation that significantly heightens a person's chance of developing a progressive and severe form of multiple sclerosis. While no single factor is responsible for causing the neurological disease, the discovery points to possible treatment options.